Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
about
The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglyceridesThe paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic researchIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?Thyroid hormone regulates the hypotriglyceridemic gene APOA5Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndromeO2 enhancement of human trophoblast differentiation and hCYP19 (aromatase) gene expression are mediated by proteasomal degradation of USF1 and USF2GSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2.Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancerThe E-box binding factors Max/Mnt, MITF, and USF1 act coordinately with FoxO to regulate expression of proapoptotic and cell cycle control genes by phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3 signalingGenetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosisAssociation of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.Activation of hepatic lipase expression by oleic acid: possible involvement of USF1.Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.Unraveling the complex genetics of familial combined hyperlipidemia.The multifaceted role of mTORC1 in the control of lipid metabolismUpstream stimulatory factors 1 and 2 mediate the transcription of angiotensin II binding and inhibitory protein.Identification and characterization of cyclic AMP response element-binding protein H response element in the human apolipoprotein A5 gene promoter.Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation.The genetics of familial combined hyperlipidaemia.The role of apolipoprotein A5 in obesity and the metabolic syndrome.Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays.Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio.Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke.
P2860
Q21261422-E5667A8B-F27C-4C1F-92AD-4F473FC2B423Q28275573-E0F87456-9853-4BD7-B35E-5B22D1222163Q28294769-9624BBAD-DD03-4E6C-9D13-4777A34BCF12Q28569807-94FDB10E-19FD-4BDC-8351-2BF3F5DC1194Q34057144-6126A47E-7333-4EB8-8C8F-2F1ED80FD54AQ34097209-C448478E-7D53-4545-9EE1-20E98F411A97Q34216085-02B22E84-B9BB-4F40-8FF4-94AD2A221D05Q35094487-A9AC2E1C-AC6E-4A81-999F-579A7313C83FQ35378529-0B8B22BE-904A-4978-B0C4-C212C450CB4CQ35575550-B8E4AE82-439C-445C-A1DC-287D7A896601Q35591965-8240B260-9CAE-4BDD-A2E8-BE14D80BAC4BQ35592272-D6D25D22-40B9-4780-B995-6498F80897F9Q35670791-DD61A8D3-AA3A-454B-8130-DB56A29C95ABQ36362933-A9FFF982-A79F-43B1-9F89-D7C7AF69DECBQ36496770-C313AC8D-47A0-47C8-AE27-3430535F83A7Q36580345-05A337EA-9300-4988-BD21-6FA4232C7160Q36659049-A754DB2D-BE3C-4DC6-8EF4-507B64940F40Q36967420-51A0EA0E-9ED4-464C-8CFE-53910607A8E9Q37061267-71AD4D46-942D-4472-B929-67C1896F7CC4Q37254095-BD5663E2-9573-4C22-BBF9-AD284A7C42DFQ37983699-612C387F-E887-4CC0-A5A5-0CC041BD4C3CQ38070859-C295F20E-A77A-4047-9A8C-A4B6D326A603Q38319977-2EB806CE-98BB-4A1F-B2C1-AB95CC345AE8Q39805075-7AB43081-A74A-4027-9734-AD3F14BA9077Q46493763-47A14E95-6AD6-4803-8091-07F24FE47B1EQ53602753-5F643E2F-BF80-4312-BAA8-9F05E7D0D418
P2860
Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@ast
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@en
type
label
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@ast
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@en
prefLabel
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@ast
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@en
P2093
P2860
P50
P1476
Insulin-mediated down-regulati ...... f upstream stimulatory factor.
@en
P2093
Audrey Helleboid-Chapman
Daniel Duran-Sandoval
Edward M Rubin
Geneviève Martin
Heidelinde Jakel
Jamila Fruchart-Najib
Len A Pennacchio
Maxime Nowak
P2860
P304
P356
10.1128/MCB.25.4.1537-1548.2005
P407
P577
2005-02-01T00:00:00Z